Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients

Objective. To investigate the efficacy and safety of the treatment of the newly diagnosed multiple myeloma (MM) patients with the therapy of subcutaneous (subQ) administration of bortezomib and dexamethasone plus thalidomide (VTD) regimen. Methods. A total of 60 newly diagnosed MM patients were anal...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Main Authors: Wu, Shenghao, Zheng, Cuiping, Chen, Songyan, Cai, Xiaoping, Shi, Yuejian, Lin, Bijing, Chen, Yuemiao
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575715/
https://ncbi.nlm.nih.gov/pubmed/26425561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/927105
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares